Predictability of rehospitalisation over 5 years for schizophrenia, bipolar disorder and depression

被引:28
|
作者
Daniels, BA
Kirkby, KC
Hay, DA
Mowry, BJ
Jones, IH
机构
[1] Univ Tasmania, Div Clin Sci, Hobart, Tas 7001, Australia
[2] Curtin Univ Technol, Sch Psychol, Perth, WA 6001, Australia
[3] Wolston Pk Hosp, Brisbane, Qld, Australia
关键词
bipolar disorder; depression; rehospitalisation; schizophrenia;
D O I
10.3109/00048679809062740
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The aim of this study was to examine the rate of rehospitalisation for schizophrenia, bipolar disorder and depression over a 5-year period in Tasmania, and to identify predictors of the number and duration of readmissions. Method: The Tasmanian Mental Health Register was used to study the 5-year pattern of rehospitalisation for all patients admitted to a Tasmanian public psychiatric inpatient facility with a primary diagnosis of schizophrenia, bipolar disorder or depression, in 1983 or 1984. Results: Seventy-one percent of patients receiving a diagnosis of schizophrenia were readmitted in the 5-year period, compared to 59% for bipolar disorder and 48% for depression. For all three diagnoses, the number of prior admissions was a predictor of the number of readmissions and the total number of days spent in hospital in the follow-up period. Age and sex also had significant effects, which varied across diagnostic groups. Conclusions: A substantial proportion of patients hospitalised for schizophrenia, bipolar disorder or schizophrenia were rehospitalised during the next 5 years. Patients with more previous admissions had more readmissions than those with fewer previous admissions.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [21] Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder
    Wysokinski, Adam
    Margulska, Aleksandra
    Strzelecki, Dominik
    Kloszewska, Iwona
    NORDIC JOURNAL OF PSYCHIATRY, 2015, 69 (05) : 346 - 353
  • [22] Exploring the ability of vocal biomarkers in distinguishing depression from bipolar disorder, schizophrenia, and healthy controls
    Pan, Wei
    Deng, Fusong
    Wang, Xianbin
    Hang, Bowen
    Zhou, Wenwei
    Zhu, Tingshao
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [23] Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression
    Callaghan, Russell C.
    Veldhuizen, Scott
    Jeysingh, Trincy
    Orlan, Chloe
    Graham, Candida
    Kakouris, Gwen
    Remington, Gary
    Gatley, Jodi
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 48 (01) : 102 - 110
  • [24] Visualization of AMPA Receptors in Patients With Depression, Bipolar Disorder, and Schizophrenia: The First PET Imaging Study
    Miyazaki, Tomoyuki
    Uchida, Hiroyuki
    Nakajima, Waki
    Hatano, Mai
    Tani, Hideaki
    Nagai, Nobuhiro
    Koizumi, Teruki
    Nakajima, Shinichiro
    Mimura, Masaru
    Takahashi, Takuya
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 302 - 303
  • [25] Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia
    Sajatovic, M
    Friedman, SH
    Sabharwal, J
    Bingham, CR
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2004, 17 (01) : 3 - 8
  • [26] Is functional impairment stable in patients with bipolar disorder and schizophrenia over time?
    Lopez-Villarreal, A.
    Jimenez-Lopez, E.
    Sanchez-Morla, E. M.
    Aparicio, I.
    Rodriguez-Jimenez, R.
    Vidal Perez, P.
    Santos, J. L.
    EUROPEAN PSYCHIATRY, 2020, 63 : S670 - S670
  • [27] Homer1a protein expression in schizophrenia, bipolar disorder, and major depression
    Leber, Stefan L.
    Llenos, Ida C.
    Miller, Christine L.
    Dulay, Jeannette R.
    Haybaeck, Johannes
    Weis, Serge
    JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (10) : 1261 - 1273
  • [28] Quality of Life of Individuals with Bipolar Disorder and Schizophrenia
    Celik, Hidayet Ece Arat
    Ceylan, Deniz
    Bagci, Basak
    Akdede, Berna Binnur
    Alptekin, Koksal
    Ozerdem, Aysegul
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2022, 59 (04): : 309 - 314
  • [29] Level of Thyroid-Stimulating Hormone (TSH) in Patients with Acute Schizophrenia, Unipolar Depression or Bipolar Disorder
    Adam Wysokiński
    Iwona Kłoszewska
    Neurochemical Research, 2014, 39 : 1245 - 1253
  • [30] Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression
    Canli, Derya
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (08): : 472 - 476